We focus on clinic-ready compounds and can accommodate a wide range of partnering structures. Our approach allows us to determine the best drug candidates without any inherent internal biases, thus circumventing the potential challenges and low probabilities of success associated with early research efforts. 

Contact us at oib.e1721791857rof@r1721791857entra1721791857p1721791857 to discuss a potential collaboration.